P3 Health Partners Financials - Benzinga

P3 Health Partners Inc

PIIINASDAQ

Trade with Public

Trade with Public

$8.98

-0.37-3.96%

At close: Sep 8, 5:00 PM EST

$9.38

0.404.49%

After Hours: Aug 27, 6:42 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

P3 Health Partners Financials

P3 Health Partners (PIII) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
P3 Health Partners Q2 EPS $(0.63) Beats $(1.90) Estimate, Sales $386.381M Beat $377.950M Estimate

Benzinga Newsdesk

PRO
P3 Health Partners Narrows FY2026 Sales Guidance from $1.500B-$1.650B to $1.500B-$1.600B vs $1.524B Est

P3 Health Partners (NASDAQ:PIII) narrows FY2026 sales outlook from $1.500 billion-$1.650 billion to $1.500 billion-$1.600 billion vs $1.524 billion estimate.

Benzinga Newsdesk

P3 Health Partners (PIII) Stock Surges Over 42% After Hours: Here's Why

P3 Health Partners Inc. shares surged 42.68% in after-hours trading after reporting first-quarter 2026 results that showed a narrower loss than expected.

Mohd Haider

PRO
P3 Health Partners Narrows FY2026 Sales Guidance from $1.500B-$1.700B to $1.500B-$1.650B vs $1.539B Est

P3 Health Partners (NASDAQ:PIII) narrows FY2026 sales outlook from $1.500 billion-$1.700 billion to $1.500 billion-$1.650 billion vs $1.539 billion estimate.

Benzinga Newsdesk

PRO
P3 Health Partners Q1 EPS $(1.72) Beats $(3.28) Estimate, Sales $386.390M Miss $391.500M Estimate

P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(1.72) per share which beat the analyst consensus estimate of $(3.28) by 47.56 percent. This is a 72.61 percent increase over losses of $(6.28) per share

Benzinga Newsdesk

Earnings Scheduled For May 14, 2026

Benzinga Insights